Dr. Wyszynski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1801 Century Park East
Los Angeles, CA 90067
Clinical Expertise
- Pregnancy, Epidemiologic typing, Epidemiology, Consultative service to pharmaceutical companies, Pregnancy registries, Drug Safety and Pharmacovigilance
Education & Training
- University of Buenos AiresClass of 1991
- Johns Hopkins School of Hygiene and Public HealthMHS, Epidemiology
- Johns Hopkins School of Hygiene and Public HealthPhD, Epidemiology
Awards, Honors, & Recognition
- TEDMED Research Scholar TEDMED, 2017
Clinical Trials
- COVID-19 Vaccines International Pregnancy Exposure Registry Start of enrollment: 2021 Jun 01
- COVID-19 International Drug Pregnancy Registry Start of enrollment: 2021 Dec 01
- Pregistry International Pregnancy Exposure Registry (PIPER) Start of enrollment: 2022 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsAssociation between SARS-CoV-2 infection during pregnancy and postpartum depressive and anxiety symptoms: finding from the International Registry of Coronavirus Exposu...Sonia Kim, Sonia Hernández-Díaz, Yanmin Zhu, Diego Wyszynski, Krista F Huybrechts
Archives of Women's Mental Health. 2022-12-01 - 22 citationsPregnancy and Birth Outcomes among Women with Idiopathic Thrombocytopenic PurpuraDiego F. Wyszynski, Wendy J. Carman, Alan B. Cantor, John M. Graham, Liza Kunz
Journal of Pregnancy. 2016-03-22 - 11 citationsFrequency and type of medications and vaccines used during pregnancyDiego F Wyszynski, Kristine E Shields
Obstetric Medicine. 2016-03-01
Press Mentions
- Dr. Cheryl Renz Joins Pregistry as Chief Medical OfficerMay 18th, 2022
- Announcing the TEDMED 2017 Research ScholarsMarch 1st, 2017
- Study Finds Anticonvulsant Drug Poses Greater Birth-Defect Risk Than SuspectedMarch 22nd, 2005
- Join now to see all
Professional Memberships
- International Society of Pharmacovigilance (ISoP)Member
Other Languages
- Spanish
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: